joimax received FDA 510(k) clearance to market Vaporflex® and Legato® electrosurgical probes with radiowave technology for open and endoscopic spine surgery.
Seikagaku entered into an exclusive agreement with Zimmer Biomet for U.S. distribution of VISCO-3â„¢, a 3-injection hyaluronic acid-based viscosupplement for the treatment of knee osteoarthritis pain.
Bone Therapeutics will not pursue U.S. clinical development of PREOB® autologous cell therapy. In the U.S., priority will be given to the development of ALLOB®, with clinical programs to be developed during 2017.
EOS imaging received FDA 510(k) clearance to market kneeEOS, online software that uses weight-bearing 3D images and data to plan Total Knee Arthroplasty.
Mighty Oak Medical received a second FDA 510(k) clearance for FIREFLY® Pedicle Screw Navigation Guides, extending compatibility to essentially all currently cleared pedicle screw systems and extending indications to include the T1-S2/ilium region.
Study results demonstrated that Silver Bullet Therapeutics’ OrthoFuzIon® Antimicrobial Bone Screw was able to significantly disrupt the development of biofilms compared to traditional, uncoated titanium screws.